123 / 160
675
[El rol de la endoscopIa avanzada en enfermedades inflamatorias intestinales... - Dra. Macarena Hevia L. y col.]
colonoscopy. Gastrointest Endosc 2004;60, n.3: 334–9.
21. Laine L, Kaltenbach T, Barkun A, McQuaid K, Subramanian V,
Soetikno R et al. SCENIC international consensus statement
on surveillance and management of displasia in inflammatory
bowel disease. Gastrointestinal Endoscopy 2015;81:489-501.
22. Rubin D. Why it’s time for updated U.S. colorectal cancer
prevention guidelines in inflammatory bowel disease.
Gastrointestinal Endoscopy 2014;80:849-851.
23. Annese V, Daperno M, Rutter M, Amiot A, Bossuyt P, East J
et al. European evidence based consensus for endoscopy in
inflammatory bowel disease. Journal of Crohn’s and Colitis
2013; 7, n.12: 982–1018
24. Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are
dysplasia and colorectal cancer endoscopically visible in
patients with ulcerative colitis? Gastrointest Endosc 2007; 65,
n.7: 998–1004.
25. Naymagon S, Marion J. Surveillance in Inflammatory Bowel
Disease, Chromoendoscopy and Digital Mucosal Enhancement.
Gastrointest Endoscopy Clin N Am 2013; 23: 679–694
26. Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M,
Kanzler S et al. Methylene blue-aided chromoendoscopy for
the detection of intraepithelial neoplasia and colon cancer in
ulcerative colitis. Gastroenterology 2003;124, n.4:880–8.
27. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot
IC. Pancolonic indigo carmine dye spraying for the detection of
dysplasia in ulcerative colitis. Gut 2004;53, n.2: 256–60.
28. Subramanian V, Mannath J, Ragunath K, Hawkey CJ. Meta-
analysis: the diagnostic yield of chromoendoscopy for detecting
dysplasia in patients with colonic inflammatory bowel disease.
Aliment Pharmacol Ther 2011;33, n.3:304–12.
29. Wu L, Li P, Wu J, Cao Y, Gao F. The diagnostic accuracy of
chromoendoscopy for dysplasia in ulcerative colitis: meta-
analysis of six randomized controlled trials. Colorectal Dis
2012;14:416–20.
30. Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. The
value of serum CA 19-9 in predicting cholangiocarcinomas in
patients with primary sclerosing cholangitis. Dig Dis Sci 2005;
50: 1734-1740
31. Samimi R, Flasar MH, Kavic S, Tracy K, Cross RK. Outcome of
medical treatment of stricturing and penetrating Crohn’ s
disease: a retrospective study. Inflamm Bowel Dis 2010; 16:
1187-1194
32. Hassan C, Zullo A, De Francesco V, Ierardi E, Giustini M, Pitidis
A et al. Systematic review: Endoscopic dilatation in Crohn’s
disease. Aliment Pharmacol Ther 2007; 26: 1457-1464
33. Gustavsson A, Magnuson A, Blomberg B, Andersson M,
Halfvarson J, Tysk C. Endoscopic dilation is an efficacious and
safe treatment of intestinal strictures in Crohn’s disease. Aliment
Pharmacol Ther 2012; 36: 151-158
34. Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW et
al. Ileal pouch-anal anastomoses complications and function
in 1005 patients. Ann Surg 1995; 222: 120-127.
35. Wu XR, Wong RC, Shen B. Endoscopic needle-knife therapy for
ileal pouch sinus: a novel approach for the surgical adverse
event (with video). Gastrointest Endosc 2013; 78: 875-885
36. Wise PE, Schwartz DA. The evaluation and treatment of Crohn
perianal fistulae: EUA, EUS, MRI, and other imaging modalities.
Gastroenterol Clin North Am 2012; 41: 379-391
37. Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE,
Tremaine WJ et al. A comparison of endoscopic ultrasound,
magnetic resonance imaging, and exam under anesthesia
for evaluation of Crohn’s perianal fistulas. Gas- troenterology
2001; 121: 1064-1072.
38. Björnsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant
strictures in patients with primary sclerosing cholangitis. Am J
Gastroenterol 2004; 99: 502-508.
39. Van Milligen de Wit AW, van Bracht J, Rauws EA, Jones
EA, Tytgat GN, Huibregtse K. Endoscopic stent therapy for
dominant extrahepatic bile duct strictures in primary sclerosing
cholangitis. Gastrointest Endosc 1996; 44: 293-299.